NCT00002018View on ClinicalTrials.gov

Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Interferon alfa-n3

Trial Locations (1)

10029

Mount Sinai Med Ctr, New York

Sponsors
All Listed Sponsors
lead

Interferon Sciences

INDUSTRY